GSK

Business

GSK raises profit outlook on strong vaccine and HIV drug sales

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…

Read More »
Business

GSK completes acquisition of Aiolos Bio for up to $1.4 billion By Reuters

© Reuters. FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo LONDON (Reuters)…

Read More »
Business

Ireland to compensate medical trial victims but GSK refuses to contribute

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…

Read More »
Business

GSK agrees to buy respiratory medicine specialist Aiolos Bio for $1.4bn

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…

Read More »
Business

GSK on hunt for drug deals in China

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…

Read More »
Back to top button